4/A
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-20-012027
SVP, General Counsel and Sec bought 15,125 shares at an average $7.90 ($119,433)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Colin SVP, General Counsel and Sec | 2019-06-07 | Purchase | +100 | $7.35 | $735 | 2,100 | D: show line 1 in the form |
| Sandercock Colin SVP, General Counsel and Sec | 2019-06-10 | Purchase | +15,025 | $7.90 | $118,698 | 17,125 | D: show line 2 in the form |
| Open-market purchases · 15,125 sh · avg $7.90 · $119,433 | |||||||
Loading xslF345X03/doc4a.xml…